Gene-Editing heart therapy under 15-Year watch
NCT ID NCT06112327
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 116 people who received an experimental gene-editing therapy for heart disease or high cholesterol. Researchers will monitor them for 15 years to track any side effects and how well the treatment controls cholesterol levels. The goal is to understand the long-term safety and effectiveness of this one-time therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROTIC CARDIOVASCULAR DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Study Center
Auckland, New Zealand
-
Clinical Study Center
Christchurch, New Zealand
-
Clinical Study Center
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill tame high cholesterol?
- Your smartwatch may predict a heart attack days before it happens
- Ancient herbal mix put to the test against high cholesterol
- Cookies that could fight cholesterol: pumpkin seeds and walnuts put to the test
- Could a daily pill help kids with inherited high cholesterol?
- Could an arthritis drug shield heart and kidneys in metabolic syndrome?